Evidence map›Paper›PMID 36839718›Full record

ArticlePharmaceutics2023

Choosing an Optimal Solvent Is Crucial for Obtaining Cell-Penetrating Peptide Nanoparticles with Desired Properties and High Activity in Nucleic Acid Delivery.

Abhijit Biswas, Maria Maloverjan, Kärt Padari, Aare Abroi, Margus Rätsep, Sebastian K T S Wärmländer, Jüri Jarvet, Astrid Gräslund, Vambola Kisand, Rünno Lõhmus and 1 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Abhijit BiswasInstitute of Technology, University of Tartu, 1 Nooruse Street, 50411 Tartu, Estonia.
Maria MaloverjanInstitute of Technology, University of Tartu, 1 Nooruse Street, 50411 Tartu, Estonia.ORCID 0000-0003-1117-3591
Kärt PadariInstitute of Molecular and Cell Biology, University of Tartu, 23b Riia Street, 51010 Tartu, Estonia.
Aare AbroiInstitute of Technology, University of Tartu, 1 Nooruse Street, 50411 Tartu, Estonia.ORCID 0000-0001-5644-8080
Margus RätsepInstitute of Physics, University of Tartu, 1 Wilhelm Ostwaldi, 51014 Tartu, Estonia.ORCID 0000-0002-7052-450X
Sebastian K T S WärmländerChemistry Section, Stockholm University, Arrhenius Laboratories, SE-10691 Stockholm, Sweden.ORCID 0000-0003-3917-1838
Jüri JarvetChemistry Section, Stockholm University, Arrhenius Laboratories, SE-10691 Stockholm, Sweden.ORCID 0000-0002-7863-1887
Astrid GräslundChemistry Section, Stockholm University, Arrhenius Laboratories, SE-10691 Stockholm, Sweden.
Vambola KisandInstitute of Physics, University of Tartu, 1 Wilhelm Ostwaldi, 51014 Tartu, Estonia.ORCID 0000-0001-9765-055X
Rünno LõhmusInstitute of Physics, University of Tartu, 1 Wilhelm Ostwaldi, 51014 Tartu, Estonia.
Margus PoogaInstitute of Technology, University of Tartu, 1 Nooruse Street, 50411 Tartu, Estonia.
University of Tartu · EEStockholm University · SE

Funding

Estonian Research Council PRG1169Estonian Research Council PRG1198Estonian Research Council PRG1506Institute of Technology, University of Tartu PLTTI20912
6 · The paper itself

Abstract

Cell-penetrating peptides (CPPs) are highly promising transfection agents that can deliver various compounds into living cells, including nucleic acids (NAs). Positively charged CPPs can form non-covalent complexes with negatively charged NAs, enabling simple and time-efficient nanoparticle preparation. However, as CPPs have substantially different chemical and physical properties, their complexation with the cargo and characteristics of the resulting nanoparticles largely depends on the properties of the surrounding environment, i.e., solution. Here, we show that the solvent used for the initial dissolving of a CPP determines the properties of the resulting CPP particles formed in an aqueous solution, including the activity and toxicity of the CPP-NA complexes. Using different biophysical methods such as dynamic light scattering (DLS), atomic force microscopy (AFM), transmission and scanning electron microscopy (TEM and SEM), we show that PepFect14 (PF14), a cationic amphipathic CPP, forms spherical particles of uniform size when dissolved in organic solvents, such as ethanol and DMSO. Water-dissolved PF14, however, tends to form micelles and non-uniform aggregates. When dissolved in organic solvents, PF14 retains its α-helical conformation and biological activity in cell culture conditions without any increase in cytotoxicity. Altogether, our results indicate that by using a solvent that matches the chemical nature of the CPP, the properties of the peptide-cargo particles can be tuned in the desired way. This can be of critical importance for in vivo applications, where CPP particles that are too large, non-uniform, or prone to aggregation may induce severe consequences.

Indexed as

cell-penetrating peptidesnanoparticle formationnucleic acid deliverysolvent

Identifiers

PMID36839718
PMCPMC9963036
OpenAlexW4318043089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.